Sales rise 35.36% to Rs 3.79 crore
Beryl Drugs reported no net profit/loss in the quarter ended March 2015 as against net loss of Rs 0.09 crore during the previous quarter ended March 2014. Sales rose 35.36% to Rs 3.79 crore in the quarter ended March 2015 as against Rs 2.80 crore during the previous quarter ended March 2014.For the full year,net profit declined 3.33% to Rs 0.29 crore in the year ended March 2015 as against Rs 0.30 crore during the previous year ended March 2014. Sales declined 7.97% to Rs 13.63 crore in the year ended March 2015 as against Rs 14.81 crore during the previous year ended March 2014.
ParticularsQuarter EndedYear EndedMar. 2015Mar. 2014% Var.Mar. 2015Mar. 2014% Var.Sales3.792.80 35 13.6314.81 -8 OPM %-0.26-4.29 -5.365.06 - PBDT0.06-0.01 LP 0.670.75 -11 PBT0.03-0.05 LP 0.400.43 -7 NP0-0.09 100 0.290.30 -3
Powered by Capital Market - Live News
